in both testicular and prostatic tumours. and the extensive discussion between sections is particularly useful for tying together the different assays and opposing views.
Other topics well covered are in the section on animal models and attempts at demonstrating specific antitumour immunity. From the clinical point of viewi the section on immunotherapy clearly indicates that little has yet been achieved, but as none of the studies reported had more than 20 patients, the positive results in the studies of BCG in bladder and kidney tumour did provide some encouragement.
The final section relates to studies of tumour regression after cryosurgery to the prostate. In a disease where chemotherapy has contributed little, this approach obviouslv deserves further evaluation.
This Progress is an optimist's word for change.
This excellent series of books returns once again (the 3rd time in 25 volumes) to tumour immunology, to document recent changes in the topic. The emphasis of this volume is on the clinical achievements of tumour immunology, and consequently it provides few signs of anything that even an optimist would call progress.
In the first 60 pages Dr Victor Richards attempts the impossible by trying to summarize the whole of immunology in a chapter which he calls an "overview". This results, as one might expect, in oversights. Proofreading errors are abundant (e.g. "homograft resection" and 'anti-idiopathic cells"). The use of outdated terminology and his enthusiasm for blocking factors conveys a powerful sense of deja vu. He states with confidence (on p. 26) that every human neoplasm, adequately studied, contains specific antigens which elicit host responses. He may well be right, but such an uncritical acceptance of inadequate data is surprising. Ending, of course, on a note of exuberant optimism he tells us (in a cliche repeated by other contributors) that 'immunotherapy of human cancer is in its infancy". This remarkable case of arrested development is clearly documented in the rest of the book.
Apart from a useful section written by the Montreal group on immunological methods of diagnosis, the rest are familiar and optimistic accounts of immunotherapy. Between them the various authors weave a web of Byzantine complexity in their attempts to convince us that immunotherapy is, or is about to become, an effective form of treatment. Much of the evidence presented of the benefits of BCG, transfer factor, immune RNA, levamisole and specific antibodies is poorly controlled, and any attempt by your humble reviewer to detail the inadequacies of these studies would undoubtedly attract the attentions of Koestler's Society for the Prevention of Cruelty to Dead Horses.
By concentrating on the clinical aspects of tumour immunology this disappointing book might lead one to suppose that there has been little progress in this subject over the past 10 years. There have been substantial changes, but then, change is a pessimist's word for progress.
G. A. CURRIE
Malignancies of the Ovary, Uterus and Cervix. R. S. BUSH (1979) . London: Arnold. 243 pp. £13.95. This is the second book in a 'Management of Malignant Disease Series" and is concerned with those aspects of the major gynaecological malignancies which contribute to the final decisions about treatment. Dr Bush starts with a very necessary discussion on "End points for evaluating treatment" that will be of benefit to anyone not working directly in the onocological field.
The body of the text is devoted to the 3 major gynaecological malignancies, carcinomas of the ovary, uterine body and cervix, and they are presented in the standard form: natural history, evaluation and management. There is no attempt to go into the technical details of the surgical and radiotherapeutic treatments involved, except where these relate to the different management schemes.
In tackling these difficult subjects the author manages to present well reasoned arguments that lead to an understanding of the Princess Margaret approach. The text
